Literature DB >> 24548454

A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.

Antonella Greco1, Angelo Massimiliano D'Erme, Barbara Zamma Gallarati, Roberto Caputo, Maurizio de Martino.   

Abstract

Infantile hemangiomas (IHs) are the most common proliferating embrional tumors of infancy, which are constituted by endothelial cell hyperproliferation. The authors want to report their observations of further 14 patients suffering from complicated IHs involving the facial district who were treated with propranolol. 14 patients, with ages between 3 and 12 months, completed a cycle of treatment with propanolol. The observational study aimed at focusing IHs involving the facial district. The treatment with propranolol showed good to very good results in the major part of the treated young patients. The authors want to report their experience and add more data in the confirmation of the use of β-blockers for IH (either in efficacy or in safety profile), focusing on the efficacy of propanolol when IHs involve the face.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  infantile hemangioma; propanolol

Mesh:

Substances:

Year:  2014        PMID: 24548454     DOI: 10.1111/dth.12116

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  1 in total

1.  Oral atenolol treatment for infantile hemangiomas: clinical analysis of 133 consecutive patients.

Authors:  Ze-Liang Zhao; Chao Liu; Qi-Zhang Wang; Hai-Wei Wu; Jia-Wei Zheng
Journal:  Ann Transl Med       Date:  2021-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.